MONITORING OF TURNAROUND TIME IN DIAGNOSING CORONAVIRUS DISEASE-19 SAMPLES: NEED OF THE HOUR

Authors

  • ANUPRIYA A Department of Microbiology, Trichy SRM Medical College Hospital and Research Centre (Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai), Tiruchirapalli, Tamil Nadu, India
  • DIEGO EDWIN Department of Microbiology, Trichy SRM Medical College Hospital and Research Centre (Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai), Tiruchirapalli, Tamil Nadu, India
  • LALITHAMBIGAI J Department of Microbiology, Trichy SRM Medical College Hospital and Research Centre (Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai), Tiruchirapalli, Tamil Nadu, India
  • PRABHUSARAN N Department of Microbiology, Trichy SRM Medical College Hospital and Research Centre (Affiliated to The Tamil Nadu Dr. M.G.R. Medical University, Chennai), Tiruchirapalli, Tamil Nadu, India

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i9.42342

Keywords:

Molecular biology lab, Coronavirus disease-19, Turnaround time

Abstract

Objective: To evaluate laboratory turnaround time (TAT) and to find out the reasons for delay in TAT in diagnosing coronavirus disease (COVID) samples.

Methods: This cross-sectional, descriptive, and observational study was conducted from August 2020 to March 2021 in a Tertiary care teaching hospital. TAT was calculated from sample reception to report dispatch.

Results: Of the 4500 samples analyzed in Molecular Laboratory for the purpose of COVID diagnosis, 890 (19.7%) had delayed TAT. The average TAT of samples in Emergency and Intensive care units (ICU) is 3 h; and it is 3 h and 30 min in inpatient and outpatient (OP) services. The average prolonged TAT is 3 h and 30 min and 4 h 10 min in Emergency care, ICU services, and inpatient and OP services respectively. The reasons for prolonged TAT includes payment for tests in the cash unit, repetition of test, specimen related, reagent related, machine breakdown, and software related.

Conclusion: The TAT demonstrates the need for improvement in the pre- and post-analytical period.

Downloads

Download data is not yet available.

References

Barth JH.Clinical quality indicators in laboratory medicine. Ann Clin Biochem 2012;49:9-16. 2. Chien TI, Lu J, Kao JT, Cheng YC, Lee YF. Evaluation and improvement strategy of analytical turnaround time in the stat laboratory.J Formos Med Assoc 2007;106:558-64.

Dey B, Bharti JN, Chakraborty M. Laboratory turnaround time. Int J Health Sci Res 2013;3:82-4.

Goswami B, Singh B, Chawla R, Gupta VK, Mallika V. Turn around time (TAT) as a benchmark of laboratory performance. Ind J Clin Biochem 2010;25:376-9.

Kilgore ML, Steindel SJ, Smith JA. Evaluating stat options in an academic health centre: Therapeutic turnaround time and staff satisfaction. Clin Chem 1998;44:1597-603.

Elhoseeny T, Mohammad E. Quality of the clinical laboratory department in a specialized hospital in Alexandria, Egypt. East Mediter Health J 2013;19:81-7.

Sivaneson S, Ramaloo G, Martin G, Giddy M, George S, Rahman TA. Improving laboratory turnaround time in a high throughput medical laboratory.J Clin Chem Lab Med 2019;2:127-31.

Steindel SJ, Jones BA. Routine outpatient laboratory test turnaround times and practice patterns. Arch Pathol Lab Med 2002;126:11-8.

Chung HJ, Lee W, Chun S, Park HI, Min WK. Analysis of turnaround time by subdividing three phases for outpatient chemistry specimens. Ann Clin Lab Sci 2009;39:144-9.

Valenstein P. Laboratory turnaround time. Am J Clin Pathol 1996;105:676-88.

Howanitz JH, Howanitz PJ. Timeliness as a quality attribute and strategy. Am J Clin Pathol 2001;116:311-5.

Holland LL, Smith LL, Blick KE. Reducing laboratory turnaround time outliers can reduce emergency department patient length of stay. Am J Clin Pathol 2005;124:672-4.

Ialongo C, Porzio O, Giambini I, Bernardini S. Total automation for the core laboratory: improving the turnaround time helps to reduce the volume of ordered STAT tests.J Lab Autom 2016;21:451-8.

Imoh LC, Mutale M, Parker CT, Erasmus RT, Zemlin AE. Laboratory-based clinical audit as a tool for continual improvement: An example from CSF chemistry turnaround time audit in a South-African teaching hospital. Biochem Med 2016;26:194-201.

Bilwani F, Siddiqui I, Vaqar S. Determination of delay in turnaround time (TAT) of stat tests and its causes: An AKUH experience.J Pak Med Assoc 2003;53:65-7.

Fleisher M, Schwartz MK. Automated approaches to rapid-response testing.A comparative evaluation of point-of-care and centralized laboratory testing. Am J Clin Pathol 1995;104:18-25.

Bhagyashree KB. Monitoring of Turnaround time (TAT) in biochemistry laboratory of a tertiary care hospital in Karwar. Int J Biotechnol Biochem 2017;13:167-73.

Published

07-09-2021

How to Cite

A, A., D. EDWIN, L. J, and P. N. “MONITORING OF TURNAROUND TIME IN DIAGNOSING CORONAVIRUS DISEASE-19 SAMPLES: NEED OF THE HOUR”. Asian Journal of Pharmaceutical and Clinical Research, vol. 14, no. 9, Sept. 2021, pp. 94-96, doi:10.22159/ajpcr.2021.v14i9.42342.

Issue

Section

Original Article(s)